adipose tissue
• subcutaneous fat pad is reduced but present
• however, treatment with doxycycline reverses defects observed
|
• brown adipocytes are pale, unilocular and hypertrophic
• however, no buffalo humps are observed and treatment wit doxycycline reverses defects observed
• authors state that defects in brown adipose tissue are the same as in Ppargtm2Yba
heterozygotes
|
• brown adipocytes are pale, unilocular and hypertrophic
• however, treatment with doxycycline reverses defects observed
|
• brown adipocytes are hypertrophic
|
• gonadal fat pads are reduced compared to in wild-type mice
• however, treatment with doxycycline reverses defects observed
|
homeostasis/metabolism
• however, treatment with doxycycline reverses defects observed
• insulin levels are elevated compared to those in wild-type mice but not as high as in Ppargtm2Yba heterozygotes
|
• triglyceride levels are elevated compared to those in wild-type mice but not as high as in Ppargtm2Yba heterozygotes
• however, treatment with doxycycline reverses defects observed
|
liver/biliary system
• the liver is modestly increased in size compared to in wild-type mice
• however, treatment with doxycycline reverses defects observed
|
integument
• subcutaneous fat pad is reduced but present
• however, treatment with doxycycline reverses defects observed
|
growth/size/body
• the liver is modestly increased in size compared to in wild-type mice
• however, treatment with doxycycline reverses defects observed
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
congenital generalized lipodystrophy type 2 | DOID:0111136 |
OMIM:269700 |
J:125992 | |
familial partial lipodystrophy | DOID:0050440 |
OMIM:PS151660 |
J:125992 |